117 related articles for article (PubMed ID: 403003)
21. A dissociated induction of MCF-producing and MAF-producing T cells specific for Listeria monocytogenes in the in vitro primary culture system.
Muramori K; Mitsuyama M; Handa T; Serushago BA; Nomoto K
Immunology; 1991 Mar; 72(3):373-9. PubMed ID: 1902819
[TBL] [Abstract][Full Text] [Related]
22. Activation of reticuloendothelial system macrophages and enhancement of host resistance to a transplantable osteogenic sarcoma in mice by an extract of Brucella abortus.
Glasgow LA; Crane JL; Schleupner CJ; Kern ER; Youngner JS; Feingold DS
Cancer Treat Rep; 1978 Nov; 62(11):1931-5. PubMed ID: 282007
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells.
Nelson KA; George E; Swenson C; Forstrom JW; Hellström KE
J Immunol; 1987 Sep; 139(6):2110-7. PubMed ID: 2957449
[TBL] [Abstract][Full Text] [Related]
24. The cellular response to Listeria monocytogenes is mediated by a heterogeneous population of immunospecific T cells.
McGregor DD; Chen-Woan M
Clin Invest Med; 1984; 7(4):243-52. PubMed ID: 6442648
[TBL] [Abstract][Full Text] [Related]
25. Perforin-deficient CD8+ T cells: in vivo priming and antigen-specific immunity against Listeria monocytogenes.
White DW; MacNeil A; Busch DH; Pilip IM; Pamer EG; Harty JT
J Immunol; 1999 Jan; 162(2):980-8. PubMed ID: 9916723
[TBL] [Abstract][Full Text] [Related]
26. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
Bernstein ID
J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
[TBL] [Abstract][Full Text] [Related]
27. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
Russell PS; Chase CM; Burton RC
J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
[TBL] [Abstract][Full Text] [Related]
28. Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.
Sewell DA; Douven D; Pan ZK; Rodriguez A; Paterson Y
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):92-7. PubMed ID: 14732776
[TBL] [Abstract][Full Text] [Related]
29. Early influx of Listeria-reactive T lymphocytes in liver of mice genetically resistant to listeriosis.
Goossens PL; Marchal G; Milon G
J Immunol; 1988 Oct; 141(7):2451-5. PubMed ID: 3139760
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of macrophage-mediated antigen presentation by hemolysin-producing Listeria monocytogenes.
Cluff CW; Ziegler HK
J Immunol; 1987 Dec; 139(11):3808-12. PubMed ID: 3119719
[TBL] [Abstract][Full Text] [Related]
31. Enhanced primary resistance to Listeria monocytogenes in T cell-deprived mice.
Chan C; Kongshavn PA; Skamene E
Immunology; 1977 Apr; 32(4):529-37. PubMed ID: 415965
[TBL] [Abstract][Full Text] [Related]
32. Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors.
Holden HT; Haskill JS; Kirchner H; Herberman RB
J Immunol; 1976 Aug; 117(2):440-6. PubMed ID: 1084897
[TBL] [Abstract][Full Text] [Related]
33. Effects of cyclosporin A on experimental infection with Listeria monocytogenes.
Strauss R; Heymer B; Hof H
Clin Exp Immunol; 1985 Dec; 62(3):491-8. PubMed ID: 3936654
[TBL] [Abstract][Full Text] [Related]
34. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.
Evans R; Duffy T
J Immunol; 1985 Jun; 134(6):4255-60. PubMed ID: 3872913
[TBL] [Abstract][Full Text] [Related]
35. Immunity to Toxoplasma gondii induced in vitro in non-immune mouse macrophages with specifically immune lymphocytes.
Sethi KK; Pelster B; Suzuki N; Piekarski G; Brandis H
J Immunol; 1975 Oct; 115(4):1151-8. PubMed ID: 809507
[TBL] [Abstract][Full Text] [Related]
36. Non-specific suppression of delayed-type hypersensitivity by intrathymic injection of killed bacteria.
Kato K; Yamamoto K
Thymus; 1984; 6(1-2):79-87. PubMed ID: 6205480
[TBL] [Abstract][Full Text] [Related]
37. The mechanism of tumor growth inhibition by tumor-specific Lyt-1+2-T cells. I. Antitumor effect of Lyt-1+2-T cells depends on the existence of adherent cells.
Fujiwara H; Takai Y; Sakamoto K; Hamaoka T
J Immunol; 1985 Sep; 135(3):2187-91. PubMed ID: 3874911
[TBL] [Abstract][Full Text] [Related]
38. Study of interactions between Listeria monocytogenes and experimental tumors.
Krybus J; Bueno MA; Feder D; Andrade Júnior AF; Cabral M; Novak A; Martins MC
Rev Paul Med; 1992; 110(3):102-7. PubMed ID: 1340994
[TBL] [Abstract][Full Text] [Related]
39. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.
Fujimoto S; Greene MI; Sehon AH
J Immunol; 1976 Mar; 116(3):800-6. PubMed ID: 1254955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
